As of 2025-07-20, the Intrinsic Value of Geneuro SA (GNRO.PA) is -1.50 EUR. This GNRO.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 EUR, the upside of Geneuro SA is -4,753.28%.
Based on its market price of 0.03 EUR and our intrinsic valuation, Geneuro SA (GNRO.PA) is overvalued by 4,753.28%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.50 - -1.50 | -1.50 | -4,753.28% |
| P/E | (2.35) - (2.09) | (2.53) | -7964.0% |
| DDM - Stable | (0.84) - (2.05) | (1.45) | -4594.3% |
| DDM - Multi | (0.18) - (0.37) | (0.24) | -858.5% |
| Market Cap (mil) | 1.59 |
| Beta | 1.97 |
| Outstanding shares (mil) | 49.24 |
| Enterprise Value (mil) | 6.70 |
| Market risk premium | 5.82% |
| Cost of Equity | 23.01% |
| Cost of Debt | 5.00% |
| WACC | 7.27% |